Cuvo vs CareValidate

If you're launching or scaling a telehealth clinic in 2026, CareValidate is probably on your shortlist, and it's easy to see why. HIPAA and SOC2 badges. A LegitScript partnership. Pro and Enterprise plans, a nationwide clinician and pharmacy network, and a promise to get you live in about 30 days.

Here's the thing about telehealth platform pricing, though: it's designed to be skimmed. It is not designed to be added up.

So we added it up (every fee, every tier, every asterisk, and every silence) and put it next to Cuvo. What emerged isn't really a feature comparison. Both platforms will get you clinicians, pharmacies, compliance, and a storefront. It's a comparison of two opposite answers to one question: how should an infrastructure company make its money?

01Two models, one fundamental difference

There are only two kinds of telehealth infrastructure companies.

The first kind makes money when you do. Flat fees, published prices, your merchant account, your patients. Their revenue doesn't grow when yours does, which means they have no reason to design fees into your growth.

The second kind makes money from you. The revenue model is attached to your volume, your gross, or your medication spend (sometimes all three) with the attachment points spread across enough line items that no single one looks alarming.

Cuvo is the first kind. CareValidate, as we're about to see, is the second. Let's take them one at a time.

02The Cuvo model: nothing to meter

Cuvo's entire commercial structure fits in a paragraph, which is itself the point.

$6,000 once. That's setup, and it includes expedited LegitScript certification, the credential that keeps your Google and Meta ad accounts alive. Bought standalone with expediting, that certification runs $5,625, so the setup fee is nearly a wash on day one.

$1,000 a month, flat, starting in month three. Your first 90 days live are fee-free while you find your footing. The fee doesn't scale with orders, patients, revenue, or product lines. Everything needed to run the clinic is in it; anything beyond is a genuinely optional add-on. And it's month-to-month: no term, no lock-in, no termination negotiation, ever.

Medications at cost, from a published list. Cuvo hands you a dated, SKU-level price sheet: semaglutide injectables $35–$68 a vial, tirzepatide $68–$145, retatrutide $75–$285, orals, TRT, peptides, HRT, hair loss, sexual health, all of it, $0 markup. Consultations are $25 flat, a visible line item. You can compute your margin on every product to the dollar before you sign, and verify it on every invoice after. There are no per-patient or per-order fees of any kind.

You own everything. Patients pay into your merchant account first, and Cuvo never touches the money. Your card tokens, your patient records, your billing relationships: yours from the first transaction. You get access to 17 pharmacies and an in-house doctor network, but you can bring your own pharmacy or your own physicians whenever you like, because Cuvo doesn't make a cent on medications or consult volume and therefore has zero incentive to fence you in.

Notice what this structure makes impossible. Cuvo can't skim your processing. Can't hide margin in a med price, the list is public and the markup is zero. Can't hold your patient base hostage at exit, you already own it. The honesty isn't a promise; it's architecture.

Now look at how CareValidate charges, with that as the baseline.

03The CareValidate model: three meters running at once

Meter #1: the platform fee that starts before you do

CareValidate Pro is $2,500 a month. Enterprise is $5,000. Both start on day one, no ramp period, no launch grace. Before that comes implementation: a storefront build at $5,000 (Basic) or $7,500 (Advanced, with custom builds quoted at $10k+), a $2,500 data migration, and, hold this thought, $500 for every product category past your third on the Pro plan.

Add it up and CareValidate Pro's first year runs about $39,950 in fixed fees with the basic storefront. Enterprise? Roughly $69,950. Cuvo's first year, everything included: $16,000. Year two onward: about $32,450 versus $12,000.

Meter #2: the fee that grows every time you do

CareValidate charges a Patient Support Fee, billed per order, per month. On the Pro plan your first 250 orders are "included." After that: $5 per order. Past a thousand: $4. Past five thousand: $3.

Pause on what that means. Every order past 250 (every patient your marketing dollars acquired, every refill your retention work earned) generates a recurring fee to CareValidate. Your success is a billable event. On Cuvo the same number is zero, at every volume, forever.

Meter #3: the one percent you'll never see on an invoice

Payment processing on CareValidate runs through CareValidate's Stripe account at 3.9%.

A direct Stripe account of your own costs roughly 2.9% plus thirty cents. CareValidate's mandatory rate is a full point higher, meaning approximately one percent of every dollar your patients ever pay you flows to CareValidate, forever, dressed up as a processing rate. On $2.4M of annual revenue, that costume is worth about $24,000 a year.

"I'll just use my own Stripe account." You can, but only on Enterprise. On the Pro plan, your patients' payments and your cards-on-file live inside CareValidate's Stripe account, full stop. The right to run your own payment rails (the thing that makes your patient base portable) is gated behind the $2,500-a-month jump to the Enterprise tier.

Read that again: on CareValidate, owning your own billing relationship is a $30,000-a-year upgrade. On Cuvo, it's the default. There's no tier where it isn't, because there's only one tier.

04Head to head: run all three meters at once

Here's monthly platform overhead as you grow, CareValidate Pro (marginal-tier support fees, $200 average order, 3.9% versus direct Stripe rates) against Cuvo's flat $1,000:

At five thousand orders a month you'd pay CareValidate thirty-two times Cuvo's flat fee, for the crime of having built a successful clinic. That's revenue-share economics wearing a SaaS costume. Splitting the take across three line items doesn't change what it is.

And we haven't reached the biggest number yet, because the biggest number isn't published at all.

05The price you can audit vs. the price you're never shown

Break CareValidate's cost structure into its categories and count how many resolve to a number you can actually see. Platform fee: visible. Support fee: visible. Labs: visible. Processing: visible. And then:

• Medications → available on request, behind a link, not published
• Provider consultations → "included in medication pricing"
• Medication shipping → "included in medication pricing"

Three cost lines (including the two biggest in any telehealth P&L) disappear into a medication price CareValidate doesn't publish. And once the consult and the shipping are "included" in the med price, the med price stops being a cost. It becomes the margin vehicle. You can't compute CareValidate's take before signing, can't audit it after, and every quiet adjustment to "medication cost" silently reprices your entire business. (For a hint at where the bundled economics land, third-party coverage of CareValidate's own consumer GLP-1 brand cites compounded programs starting around $297 a month retail.)

Set that against Cuvo's published, dated, SKU-level at-cost list with a visible $25 consult, and this stops being a pricing comparison and becomes an epistemology comparison: one platform lets you audit your unit economics; the other asks you to trust them.

Oh, and labs: CareValidate prices them at an $80 flat fee, advertised, in their own words, "with ability to mark-up." The pitch is literally coaching you to upcharge your patients' bloodwork. Cuvo just passes labs through. Make of that what you will.

06The certification you own vs. the one you rent

LegitScript matters: it's what protects your ad accounts and your payment processing. Cuvo includes expedited certification in the $6,000 setup: one time, done, yours.

CareValidate sells it as a subscription: $205 a month, or $2,450 a year, in perpetuity. Three years in, you've paid $7,350 and you're still paying. And note how they describe the service: they handle the application and add the certification to your website. Whose certification is it? Does it survive if you leave the platform? Nothing we've seen answers that. "The credential that keeps my business advertisable might be tethered to my vendor" is a question you want answered in writing, not discovered later.

While we're on rented things: the Enterprise plan softens its $5,000 fee with per-order "credits," but they only begin at 500 orders a month, are applied against the following month's invoice, and at the 500–999 tier max out around $2,000 against a $5,000 charge. You pay full freight and chase a partial rebate a month behind. A discount you have to earn back monthly isn't a discount. It's a leash.

07What CareValidate goes very quiet about

Here's our favorite part of evaluating any platform: the silences.

CareValidate will tell you its product-category fee to the dollar. It specifies phone support hours to the hour, 9a to 8p Eastern, weekdays only, meaning your patient with an injection question on Saturday night gets a text queue. It will even tell you, up front, everything that can void the 30-day launch promise: customization, product groups, your own responsiveness, and, delightfully, the turnaround time of the very LegitScript certification it charges $205 a month for.

But try to find answers to the questions that actually decide whether your business survives the relationship: What's the contract term? What's the termination clause? Who owns the patient data? Is there a data export commitment, format, timeline, anything? What happens to your storefront, your tokens, your billing if you leave? We couldn't find any of it. The only migration CareValidate prices anywhere is $2,500, for moving your data in. Getting out is unpriced, undescribed, and unmentioned. Combine that with Pro-plan payments living inside CareValidate's Stripe and a patient portal that is CareValidate's product, and the exit picture looks uncomfortably familiar to anyone who read our OpenLoop breakdown: leaving means rebuilding billing and re-consenting patients from zero.

With Cuvo, these questions don't need contract language, because the architecture answers them: month-to-month, and everything worth owning (records, tokens, merchant account, patients) was yours the whole time. With CareValidate, demand written answers on five things before signing anything: term, termination, data export, card-token portability, LegitScript portability.

As for the headline metrics in CareValidate's marketing ("3:1 ROI in year 1," "80% reduction in operational spend," "20x patient volume in 60 days"), that last one rests on a single unnamed case study, and none of the three comes with methodology, baseline, or cohort size. The numbers doing the selling are the least verifiable numbers in the pitch.

One more data point on who you'd be building on: CareValidate began as a COVID-era workplace product (Care360 / PandemicCare, doing employee screening, testing, and contact tracing) then pivoted through employee-wellness apps into GLP-1 telehealth as that market receded. Pivots are legitimate. But when a vendor holds your payment rails, patient records, and compliance credential, it's fair to ask how deep the bench is in this business, and where you'd land if the market shifts and they pivot again. Cuvo's answer to that risk, once more, is structural: even in the worst case, you own everything, so you leave whole.

08To be fair

CareValidate is not vapor. SOC2 Type II is real. The HIPAA posture, 503A/503B pharmacy relationships, 50-state coverage, sync and async visits, Spanish-language support, and RN case monitoring are real; LegitScript itself features them as a customer spotlight, and their analytics tooling looks genuinely useful. If CareValidate published its medication prices, let every client own their own Stripe account, sold LegitScript once instead of renting it monthly, and put its contract terms on paper, it would be a credible competitor on features.

But the features were never the product. The meter is.

09The scorecard

10The bottom line

At 1,000 orders a month, CareValidate's overhead gap versus Cuvo is roughly $89,000 a year. At 5,000, it's pushing $380,000, before anyone audits the medication margin, because nobody can audit the medication margin.

Cuvo's whole pitch fits in a sentence: $6,000 once with expedited LegitScript included, $1,000 flat from month three, month-to-month, every medication at published cost, $25 per consult, nothing per patient, with 17 pharmacies and a doctor network on tap or the freedom to bring your own, and the merchant account, card tokens, records, and patients yours from the first transaction. There's no meter to read because there's no meter.

One platform's revenue is a utility bill. The other's is a percentage of your ambition.

Choose accordingly.